Position in AMGN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$2,236,453
-$70,979 QoQ
Shares Held
6,176
-5.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#1,217
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Checchi Capital Advisers, LLC holds $38,252,347 across 13 Drug Manufacturers - General names. AMGN ranks #6 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,032 | $12,032,682 | |
| 2 | JNJ |
Johnson & Johnson
|
28,318 | $7,191,922 | |
| 3 | ABBV |
AbbVie Inc.
|
19,940 | $5,017,701 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,506 | $3,020,521 | |
| 5 | NVS |
Novartis AG
|
16,953 | $2,656,874 | |
| 6 | AMGN |
Amgen Inc
This page
|
6,176 | $2,236,453 | |
| 7 | AZN |
Astrazeneca PLC
|
9,648 | $1,829,453 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
9,839 | $1,243,059 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,236,453 | 6,176 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $2,307,432 | 6,558 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,972,697 | 6,027 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $1,698,279 | 6,018 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,881,037 | 6,737 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $2,160,287 | 6,934 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,746,548 | 6,701 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $2,144,951 | 6,657 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $2,137,470 | 6,841 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $1,916,316 | 6,740 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $2,010,667 | 6,981 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,849,606 | 6,882 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,567,905 | 7,062 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,747,610 | 7,229 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $1,941,960 | 7,394 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,867,889 | 8,287 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,003,818 | 8,236 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,683,550 | 6,962 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,425,409 | 6,336 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,364,575 | 6,417 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,585,106 | 6,503 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,701,362 | 6,838 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,590,356 | 6,917 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,773,528 | 6,978 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,664,464 | 7,057 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,490,876 | 7,354 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||